Also trades as: RVPHW (NASDAQ) · $vol 0M
RVPH Earnings
Reviva Pharmaceuticals Holdings, Inc.
1W: -2.2%
1M: -5.9%
3M: +9.8%
YTD: +45.2%
1Y: -33.4%
3Y: -89.9%
5Y: -87.0%
$0.38
-0.04 (-10.03%)
Weekly Expected Move ±8.0%
$0
$0
$0
$0
$0
Credit Risk of going bust: not rated, debt is over 20 times the stock's value Debt: 100.0% of company value Bonds: none of note held by US funds details ▾
Not rated: debt is over 20 times the stock market value, where the model breaks down (deep distress or a data error). Altman Z'' -21.86.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-08-13
EPS
$-0.19
▲ Beat +50.6%
Revenue
—
EPS Beat Streak: 6 quarters
Next Earnings
2026-11-12
EPS Estimate
$-0.28
Range: $-0.28 - $-0.28
Estimate vs Actual
Earnings Surprise History
12/18
EPS Beats
0/18
Revenue Beats
67%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | annual | 2027-12-31 | $-1.67 | $-1.15 | ▲ 0.53 | $137,297,000 | $137,297,000 |
| 2026-08-20 | quarter | 2027-03-30 | $-0.21 | $-0.19 | ▲ 0.02 | $— | $— |
| 2026-08-20 | quarter | 2027-12-30 | $-0.24 | $-0.25 | ▼ 0.01 | $— | $— |
| 2026-08-20 | quarter | 2026-12-30 | $-0.47 | $-0.28 | ▲ 0.20 | $— | $— |
| 2026-08-20 | quarter | 2027-06-30 | $-0.21 | $-0.18 | ▲ 0.03 | $— | $— |
| 2026-08-20 | annual | 2028-12-31 | $-1.30 | $-0.89 | ▲ 0.42 | $185,747,800 | $185,747,800 |
| 2026-08-20 | annual | 2026-12-31 | $-1.78 | $-1.13 | ▲ 0.65 | $5,000,000 | $5,000,000 |
| 2026-08-20 | quarter | 2026-09-30 | $-0.46 | $-0.29 | ▲ 0.17 | $— | $— |
| 2026-08-13 | quarter | 2027-12-30 | $-1.57 | $-0.24 | ▲ 1.33 | $— | $— |
| 2026-08-13 | quarter | 2027-03-30 | $-1.41 | $-0.21 | ▲ 1.20 | $— | $— |
| 2026-08-13 | quarter | 2028-03-30 | $1.25 | $-0.09 | ▼ 1.34 | $44,579,500 | $44,579,500 |
| 2026-08-13 | quarter | 2026-12-30 | $-1.16 | $-0.47 | ▲ 0.68 | $— | $— |
| 2026-08-13 | quarter | 2028-12-30 | $1.25 | $-0.10 | ▼ 1.35 | $48,294,400 | $48,294,400 |
| 2026-07-06 | annual | 2026-12-31 | $-1.61 | $-1.78 | ▼ 0.17 | $5,000,000 | $5,000,000 |
| 2026-07-06 | quarter | 2026-06-30 | $-0.48 | $-0.39 | ▲ 0.10 | $— | $— |
Earnings Call Transcripts
No transcripts available.